The future for blood‐stage vaccines against malaria

JS Richards, JG Beeson - Immunology and cell biology, 2009 - Wiley Online Library
… The SPf66 vaccine consists of a 45 amino-acid peptide, … in a South American and a Tanzanian
study, but failed to show … African children has changed the landscape of malaria vaccine

Efficacy of the RTS, S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

PL Alonso, J Sacarlal, JJ Aponte, A Leach, E Macete… - The Lancet, 2004 - thelancet.com
… to receive three doses of either RTS,S/AS02A candidate malaria vaccine or a control vaccine
… of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. …

Plasmodium falciparum Malaria in Children Aged 0-2 Years: The Role of Foetal Haemoglobin and Maternal Antibodies to Two Asexual Malaria Vaccine Candidates …

DT Kangoye, I Nebie, JB Yaro, S Debe, S Traore… - PloS one, 2014 - journals.plos.org
children in areas of high malaria risk. Foetal haemoglobin was associated with delayed first
episode of febrile malaria … In a study conducted in Tanzania by Lusingu and colleagues, total …

Incidence of severe Plasmodium falciparum malaria as a primary endpoint for vaccine efficacy trials in Bandiagara, Mali

KE Lyke, A Dicko, A Kone, D Coulibaly, A Guindo… - Vaccine, 2004 - Elsevier
… the immune response to malaria, index cases of severe malaria in children aged 3 months
to 14 years … A trial of the synthetic malaria vaccine SPf66 in Tanzania: rationale and design …

Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean children

B Genton, F Al-Yaman, I Betuela, RF Anders, A Saul… - Vaccine, 2003 - Elsevier
… is that the boosting provided by a malaria vaccine may be more efficient in the presence of
… by a malaria vaccine was also found for IgG3 responses in Tanzanian children after SPf66

Plasmodium falciparum Blood Stage Antimalarial Vaccines: An Analysis of Ongoing Clinical Trials and New Perspectives Related to Synthetic Vaccines

DR Salamanca, M Gómez, A Camargo… - Frontiers in …, 2019 - frontiersin.org
… intensity dependent and SPf66 vaccination was thus stopped … carried out involving 45
children between 12 and 24 months … on 16 Swiss and 40 Tanzanian volunteers who were given …

Malaria vaccine trials in a wormy world

M Nacher - Trends in parasitology, 2001 - cell.com
… In the past decade, SPf66, a synthetic polypeptide malaria vaccine has been tested in
various … the association of SPf66 with 30% protection against malaria in some populations …

Molecular monitoring in malaria vaccine trials

I Felger, B Genton, T Smith, M Tanner, HP Beck - Trends in Parasitology, 2003 - cell.com
… Thus, for instance, in the first major Tanzanian trial of the SPf66 vaccine [ … No difference
was detected in the distribution of these variants between SPf66-vaccinated children and the …

[HTML][HTML] Multiclonal asymptomatic Plasmodium falciparum infections predict a reduced risk of malaria disease in a Tanzanian population

S Bereczky, A Liljander, I Rooth, L Faraja… - Microbes and …, 2007 - Elsevier
… Within a small cohort of children in an area of high transmission in Tanzania, we described
intra-individual consistency, over several years, in the number of infecting P. falciparum …

Murine infection models for vaccine development: the malaria example

K Matuschewski - Human vaccines & immunotherapeutics, 2013 - Taylor & Francis
… –5 y old children in Tanzania concluded that SPf66 was safe, immunogenic and reduced the
risk of clinical malaria by ~30%.Citation 51 Partial vaccine efficacy reportedly extended well …